MetabolomicsRx

Curated by Signal

Personalized medicine platform that utilizes AI and pharmacometabolomics to optimize drug and dose selection

Overview

Personalized medicine platform that utilizes AI and pharmacometabolomics to optimize drug and dose selection. It offers a proprietary companion diagnostic test called Pyonero which leverages a pharmacometabolomic database and patient outcome data.

Key facts

Founded: 2023
Headquarters: El Paso, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Bask Health
Provider of a software suite for pharmacies and doctors
Health TechnologyNew York City, United States
Exon Map Explorer
Provider of a gene mapping tool for healthcare professionals and researchers
Health TechnologyCambridge, United States
RadioMD
Provider of an online health information platform for multiple diseases
Health TechnologyRolling Meadows, United States

About MetabolomicsRx

What does MetabolomicsRx do?

Personalized medicine platform that utilizes AI and pharmacometabolomics to optimize drug and dose selection.

Where is MetabolomicsRx headquartered?

MetabolomicsRx is headquartered in El Paso, United States.

When was MetabolomicsRx founded?

MetabolomicsRx was founded in 2023.

Which sector is MetabolomicsRx in?

MetabolomicsRx operates in Health Technology.

Who are MetabolomicsRx's competitors?

Companies similar to MetabolomicsRx include Bask Health, Exon Map Explorer, and RadioMD.